Author Amanda Young triumphs over her painful past in Silent Prisoner.
Las Vegas, NV (PRWEB) November 21, 2007 -- Silent Prisoner by Amanda Young examines the repercussions of abuse and inspires other lonely victims to change their course in life.
In Silent Prisoner, Young reveals her agonizing past, beginning with the abuse she suffered at the hands of her alcoholic parents. Her childhood was spent being tossed around between various relatives and foster parents, and she soon found herself on a destructive path that led her from one abusive relationship to the next. Ultimately, it was Young's faith in God, along with the help of some special people that helped her recognize her own strength and enabled her to reclaim her life.
Through this book, Young gives the power of hope, faith, and personal strength to other victims and encourages them to let go of the shame and guilt that is holding them back from truly living. Sharing her faith in God and angels, Young allows readers to see that they are never alone or unworthy of love from God.
To those who have suffered abuse, Silent Prisoner serves as a torch to light the way to a new life.
"Amanda Young has offered the reader an insider's view into the world of a victim of domestic violence. Her incredible insight and perception makes for an illuminating, touching and inspirational story. A flower that blooms under adverse conditions is truly the most beautiful of all." - Dr. Jeffrey Davis, Emergency physician and Director of the Palm Beach County Trauma System
For more information or to request a free review copy, members of the press can contact the author at deniseau21 @ aol.com. Silent Prisoner is available for sale online at Amazon.com, BookSurge.com, and through additional wholesale and retail channels worldwide.
About the Author:
Amanda Young is a registered nurse with a degree in homeopathy from the British Institute of Homeopathy. She received an award in excellence for nursing assessment from St. Joseph and St. Jude Home Health. She currently resides in Las Vegas.
About BookSurge:
BookSurge Publishing is a DBA of On-Demand Publishing LLC, a subsidiary of Amazon.com Inc., (NASDAQ AMZN). BookSurge is a pioneer in self-publishing and print-on-demand services. Offering unique publishing opportunities and access for authors, BookSurge boasts an unprecedented number of authors whose work has resulted in book deals with traditional publishers as well as successful authorpreneurs who enhance or build a business from their professional expertise.
Press Contact: Kathryn DuRant
Company Name: BookSurge Publishing
Phone: 843-789-5214
Website: www.booksurge.com
Vioxx Settlement: Consumer Safety Law Firms Across U.S. Comment
Pro or Con? Plaintiff attorneys across the U.S. comment on the Merck Vioxx Settlement offer and the outcome for patients.
(PRWEB) November 10, 2007 -- After previously stating intentions to fight litigation on a case-by-case basis, Merck & Co agreed to pay $4.85 billion to settle claims that its painkiller Vioxx caused heart attacks and strokes. The popular drug was pulled from the market three years ago, and following the recall, suits were filed on behalf of 47,000 claimants across the country.
Today's announcement prompted immediate reaction among consumer safety attorneys. Law firm web consultants Consultwebs, Inc., represent numerous lawyers and firms who have clients involved in the case and who were eager to comment on the settlement.
"Great news," exclaims Attorney Carlos Diez-Arguelles of Martinez, Manglardi, Diez-Arguelles & Tejedor of Orlando, Florida. "So many people were affected by this case that we're thrilled to see Merck taking steps toward compensation."
"This case once again reinforces the role that plaintiffs' lawyers play in safeguarding the American public," says Attorney J. Christopher Munley of Pennsylvania law firm Munley, Munley & Cartwright, P.C. "The pharmaceutical industry has steadfastly denied that they had any possible life-threatening problems with their products but once again lawyers pierced the cloak of dishonesty to reveal the truth."
Robert K. Jenner, Partner, Janet, Jenner & Suggs, LLC in Baltimore, Maryland commented on the message sent by the settlement. "We are extremely pleased that our hard work uncovering the truth of the dangers of Vioxx resulted in a just result for our clients. The message to all drug makers is clear: you can't make drugs without testing them and warning about their dangers."
"Merck is heading in the right direction," says Attorney Ron Brown of Brown & Crouppen in St. Louis, Missouri. "However, there are literally tens of thousands of plaintiffs involved, so it remains to be seen whether this settlement really provides the compensation people need."
Other lawyers were more guarded about the news, including Attorney Kenneth L. Hardison of North Carolina law firm Hardison & Associates. "While the Merck settlement is a positive step, we must not overlook those plaintiffs who suffered the most. As we discuss settlement details with our clients, we want to be sure that people who experienced truly catastrophic injuries -- in some cases death -- are not denied their day in court."
Joseph L. Belluck, Partner at Belluck & Fox, LLP in New York, New York was also cautious about rushing to judge the impact of Merck's announcement. "Merck has not yet released settlement details to all plaintiff attorneys, so it's still early to evaluate whether this provides adequate resolution. However, Belluck & Fox remains committed to pursuing our client claims -- and we certainly hope that Merck considered the best interests of all 47,000 claimants in reaching this decision."
Attorney Robert A. Kraft, Kraft & Associates, P.C., Dallas, Texas, summed up the sentiments of many regarding today's news. "While the settlement amount seems wholly inadequate, considering the large number of claimants whose lives were lost or shattered due to the negligence of Merck, it is at least heartening to know that the efforts of trial lawyers across the country have forced Merck to abandon its policy of total denial. Merck knew it was facing years of relentless pressure from innocent consumers and their attorneys, and in the face of that pressure Merck has decided to follow a more reasonable path toward closure of these claims."
About Consultwebs.com
Consultwebs.com, Inc. is a full-service Internet/Web design and Web consulting company. Its primary focus is law firm Web marketing and design, and the company supports more than 300 law firm client Web sites and has worked with numerous businesses and legal organizations, such as the American Bar Association. Consultwebs.com has more than seventy-five years of combined business consulting experience. http://www.consultwebs.com
Press Contact: Lisa M. Vaughn
Company Name: Consultwebs.com, Inc.
Phone: 919-413-1757
Website: http://www.consultwebs.com
After more than five years of hard-fought and difficult litigation, Merck has agreed to pay $4.85 billion, the largest pharmaceutical settlement in history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack (including sudden cardiac death) or a stroke. Beasley Allen's Andy Birchfield and his Vioxx team of lawyers -- Benjamin Locklar, P. Leigh O'Dell, and W. Roger Smith, III -- played an integral role in the development of the Settlement Program and in Merck agreeing to settle these cases.
Montgomery, AL (PRWEB) November 9, 2007 -- After more than five years of hard-fought and difficult litigation, Merck has agreed to pay $4.85 billion, the largest pharmaceutical settlement in history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack (including sudden cardiac death) or a stroke. Beasley Allen's Andy Birchfield and his Vioxx team of lawyers - Benjamin Locklar, P. Leigh O'Dell, and W. Roger Smith, III -- played an integral role in the development of the Settlement Program and in Merck agreeing to settle these cases.
Mr. Birchfield is known nationwide as one of the leading Vioxx lawyers. He is Co-Lead Counsel of the coordinated Vioxx MDL litigation in New Orleans, and he is one of the few attorneys in the country that has tried a Vioxx case before a jury. He is one of only two lawyers nationwide who has tried Vioxx cases in both state and federal courts.
The Settlement Program will settle the claims of thousands of qualified claimants who suffered a heart attack, ischemic stroke, or sudden cardiac death resulting from Vioxx. The settlement funds will be allocated among thousands of qualifying claims based upon an evaluation of each Qualifying Claimant's medical records by a Claims Administrator. We feel the Settlement Program is fair and that it provides qualifying clients the ability to be compensated for their injuries in the foreseeable future, rather than competing for a trial date with the thousands of other Vioxx cases pending nationally.
The litigation involving product liability claims related to the pain reliever, Vioxx, has been ongoing for over five years. It is estimated that thousands personal of injury lawsuits have been filed. Discovery has been ongoing in consolidated cases throughout the country since 2001. Over 50 million pages of documents have been produced and reviewed. More than 2005 general depositions have been taken thus far. Thousands of motions have been filed and considered. Hundreds of experts in cardiology, pharmacology, neurology and other disciplines have been consulted. Moreover, over 19 trials have taken place between August 2005 and September 2007 with mixed results, including defense verdicts, plaintiff's verdicts, hung juries, and retrials.
More than 11 months ago in December 2006, Judge Eldon E. Fallon of the Federal Court in New Orleans in consultation with coordinating Judges Victoria Cheney of the Los Angeles Superior Court, Judge Carol Higbee of the New Jersey Superior Court and Judge Randy Wilson of the Harris County, Texas District Court directed Merck and Plaintiffs to begin continuous and frequent confidential negotiations.
For Plaintiffs, the Judges appointed a six-member negotiating committee which included representatives from each coordinating state, the MDL Executive Committee and a member of the MDL Steering Committee at large.
Merck designated a like number of negotiators, and the two groups were directed to seek a potential resolution of filed and tolled cases in which folks alleged that they or loved ones had suffered heart attacks, ischemic strokes or sudden cardiac death as a result of Vioxx ingestion.
Negotiating teams met in more than 50 sessions in New Orleans, Montgomery, Washington D.C., New York, Philadelphia, Los Angeles, St. Louis and Houston. Several hundred phone conferences augmented face-to-face negotiations.
The coordinating Judges, during frequently scheduled meetings and phone calls, monitored the progress of the negotiations while at the same time managing dockets of thousands of cases.
From the plaintiffs' perspective many lawyers who were involved in conducting discovery about Vioxx, developing the science liability case, and trying cases before juries demonstrated great tenacity and excellence in their efforts to secure compensation for plaintiffs who suffered injuries which we believe are a result of Vioxx.
The resulting $4.85 billion resolution is a resolution which was hard-fought and portended risks for all parties. In light of significant costs and delay that would result in protracted litigation, the Settlement Program will ensure that those who suffered injuries as a result of Vioxx are compensated fairly and efficiently.
Details regarding the Settlement Program, including eligibility and qualification requirements, may be accessed by visiting www.BeasleyAllen.com
To help understand the settlement, we have created an online settlement calculator.
About Beasley Allen:
Headquartered in Montgomery, Alabama, Beasley Allen is comprised of over 40 attorneys and 150 support staff. Beasley Allen is a national leader in civil litigation, having settled verdicts and settlements amounting to nearly $15 billion.
Andy Birchfield and Leigh O'Dell available for comment 800.898.2034.
links: www.beasleyallen.com, www.officialvioxxsettlement.com
Press Contact:
Renee Lindsey
Beasley Allen
218 Commerce Street
Montgomery, AL
800.898.2034
Press Contact: Renee Lindsey
Company Name: BEASLEY ALLEN
Phone: 800-898-2034
Website: www.beasleyallen.com
LegalView provides users with a continually updated blog on its mesothelioma site informing victims of the cancer on topics like asbestos exposure and treatments. The blog includes essential information including the various different forms of mesothelioma.
Denver, CO - November 6, 2007
LegalView, your source for everything legal on the web, recently updated its mesothelioma information portal to include an updated blog that details everyday issues for those with the deadly cancer as well as how to find a "mesothelioma lawyer. One of the issues the blog reviews are the three various types of mesothelioma that a victim can be diagnosed with. Victims must be aware of this information especially if they have been previously exposed to asbestos in any way. LegalView's blog describes the three different cell types, which are epitheloid, sarcomatoid and a fibrous mixed type, also known as biphasic type. According to the blog, epitheloid is the most common type of mesothelioma and accounts for 50 percent to 70 percent of cases today. Epitheloid is the type of mesothelioma that is most likely to respond to treatment if caught early while sarcomatoid is the most serious and less responsive to treatments.
For those who have been exposed at anytime to asbestos, which is nearly always the cause of mesothelioma, LegalView connects victims to asbestos lawyers who offer insightful legal information and consultations on the issue. Other various information located on the newly updated mesothelioma blog include symptoms and treatments of mesothelioma and how to reach a mesothelioma law firm in the event that an individual feels they need to consult a mesothelioma attorney.
In addition to the detailed information on mesothelioma, users can find valuable information on several legal issues including how to connect with nephrogenic systemic fibrosis lawyers or how to get in touch with an automobile accident attorney if such tragedy has befallen an individual. LegalView also offers a service to connect with a brain injury lawyer for victims as well as provide access to personal injury blogs, jury verdicts and newsfeeds. LegalView is sensitive to the needs of those suffering from a range of legal issues and those who feel victimized by their situation, which is why LegalView continues to provide accurate, current and vital information to those in need as well as offer attorney referral services for all legal issues on LegalView.
About LegalView:
LegalView.com is a free public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation formed by the nation's most distinguished law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez Hodes; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's well-regarded sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.
Press Contact: Katie Kelley
Company Name: LegalView
Phone: 720-771-3246
Website: http://www.LegalView.com/
CPAPtalk.com announces the Product Challenge, an industry first opportunity for CPAP manufacturers with similar products to challenge each other publicly in patient satisfaction trials.
Houston, TX (PRWEB) November 1, 2007 -- CPAPtalk.com announces the Product Challenge, an industry first opportunity for CPAP manufacturers with similar products to challenge each other publicly in patient satisfaction trials. Once a challenge has been made, CPAPtalk.com will hold an open enrollment for patient's currently using the challenged manufacturer's product. Fifty patients will be selected from those enrolled based on CPAPtalk Product Challenge vetting standards. The challenger's product will be used for two weeks and rated via a detailed satisfaction survey.
The CPAPtalk Product Challenge promotes healthy competition and an incentive for increased product quality based on customer response. This system provides patients a way to try out competing products free of charge and have their opinions heard.
Manufacturers benefit from the Product Challenge by using it to objectively prove the superiority of their product to it's competitors. This tool can be used by manufacturers looking to draw extra attention to the launch of a new product, build their brand image or expand their presence in a new niche. A manufacturer's success in the Product Challenge will provide compelling marketing material for a representative to extol the virtues of their product to diagnostic facilities and physicians.
Durable medical equipment providers benefit from free and objective measurements of product quality by patients. These tests can be used in place of or as a supplement to costly in house testing of product quality. In addition, providers have the ability to use the results as part of their own marketing collateral, promoting the best product choice for patient's.
Physicians benefit by knowing which products will best serve their patients needs and comfort. A patient recently diagnosed with Sleep Apnea trusts their physician to recommend products and a specialist that will help them combat the problem. With such a wide variety of products available it is extremely difficult to know which ones best serve patients. The CPAPtalk Product Challenge delivers results that patients and physicians alike can use to best gauge what masks, machines and accessories will help give a Sleep Apnea patient the best night sleep possible.
Initially, results of the CPAPtalk Product Challenge will be published on CPAPtalk.com, a public forum with over 200,000 posts and over 30 million page views. To see what results have been published and what product challenges will be happening in the near future, please visit http://www.cpaptalk.com/productchallenge. Results will also be reported to industry publications and winners of product challenges will be highlighted on CPAP.com.
Press Contact: Chris Brown
Company Name: CPAPtalk.com
Phone: 8003565221+222
Website: http://www.cpaptalk.com/productchallenge
